• 1. Excited state dynamics of symmetric and asymmetric Cr3(dpa)4Cl2 measured using femtosecond transient absorption spectroscopy?
  Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477
• 2. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 3. Evolution of important glucosinolates in three common Brassica vegetables during their processing into vegetable powder and in vitro gastric digestion
  Nan Fu,Naphaporn Chiewchan,Xiao Dong Chen Food Funct., 2020,11, 211-220
• 4. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 5. Fe/S-Catalyzed synthesis of 2-benzoylbenzoxazoles and 2-quinolylbenzoxazoles via redox condensation of o-nitrophenols with acetophenones and methylquinolines?
  Thi Thu Tram Nguyen,Thanh Binh Nguyen Org. Biomol. Chem., 2021,19, 6015-6020

Cyclobutanecarboxylic acid, 2,2,4,4-tetramethyl-: A Comprehensive Overview of Its Chemical Properties and Emerging Applications

Cyclobutanecarboxylic acid, 2,2,4,4-tetramethyl- (CAS No. 2138223-58-0) is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and materials science due to its unique structural and functional properties. This compound, characterized by a highly symmetric cyclobutane ring substituted with four methyl groups and a carboxylic acid functional group at the third position, exhibits distinct chemical reactivity and potential applications that are being actively explored in both academic research and industrial development.

The molecular structure of Cyclobutanecarboxylic acid, 2,2,4,4-tetramethyl- (CAS No. 2138223-58-0) imparts several advantageous features that make it a valuable building block in synthetic chemistry. The presence of the cyclobutane ring provides rigidity to the molecule, which can be beneficial in designing stable and bioactive scaffolds. Additionally, the electron-withdrawing nature of the carboxylic acid group enhances the compound's reactivity in various organic transformations, making it a versatile intermediate for the synthesis of more complex molecules.

In recent years, there has been a growing interest in exploring the pharmacological potential of cycloalkane derivatives. The symmetric structure of Cyclobutanecarboxylic acid, 2,2,4,4-tetramethyl- (CAS No. 2138223-58-0) has led researchers to investigate its possible applications in drug discovery. Studies have shown that such compounds can exhibit inhibitory effects on certain enzymes and receptors, making them promising candidates for developing novel therapeutic agents. For instance, preliminary research suggests that derivatives of this compound may have potential in modulating metabolic pathways associated with inflammation and oxidative stress.

The synthesis of Cyclobutanecarboxylic acid, 2,2,4,4-tetramethyl- (CAS No. 2138223-58-0) involves multi-step organic reactions that highlight its synthetic utility. The process typically begins with the formation of a cyclobutane precursor followed by functionalization with methyl groups and introduction of the carboxylic acid moiety. Advanced synthetic techniques such as cross-coupling reactions and ring-closing metathesis have been employed to achieve high yields and purity levels. These synthetic strategies not only demonstrate the compound's versatility but also contribute to the broader toolkit available for medicinal chemists.

One of the most intriguing aspects of Cyclobutanecarboxylic acid, 2,2,4,4-tetramethyl- (CAS No. 2138223-58-0) is its potential application in materials science. The rigid cyclobutane framework combined with bulky methyl groups makes this compound an excellent candidate for designing polymers with specific mechanical properties. Researchers are exploring its use in creating high-performance resins and coatings that exhibit enhanced thermal stability and chemical resistance. Additionally, the carboxylic acid group provides a site for further functionalization, allowing for the development of tailored materials with desired characteristics.

The spectroscopic properties of Cyclobutanecarboxylic acid, 2,2,4,4-tetramethyl- (CAS No. 2138223-58-0) have also been extensively studied to better understand its molecular interactions. Nuclear magnetic resonance (NMR) spectroscopy reveals detailed information about the compound's structure and dynamics, while infrared (IR) spectroscopy confirms the presence of functional groups such as carboxylic acids. Mass spectrometry techniques provide insights into fragmentation patterns, which are crucial for structural elucidation and purity assessment.

In conclusion, Cyclobutanecarboxylic acid, 2,2,4,4-tetramethyl- (CAS No. 2138223-58-0) represents a fascinating compound with diverse applications spanning pharmaceuticals and materials science. Its unique structural features offer opportunities for innovative research and development. As scientists continue to uncover new synthetic pathways and explore its pharmacological properties，this compound is poised to play a significant role in advancing both academic research and industrial applications.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)